TIM3 gene polymorphisms in patients with chronic hepatitis B virus infection: impact on disease susceptibility and hepatocellular carcinoma traits
Authors:
- 15 May 2012
- journal article
- research article
- Published by Wiley in Tissue Antigens
- Vol. 80 (2) , 151-157
Abstract
Hepatitis B virus (HBV) infection is associated with the development of acute and chronic liver diseases including hepatocellular carcinoma (HCC). T‐cell immunoglobulin domain and mucin domain‐containing molecule‐3 (Tim‐3), which negatively regulates T‐cell response and mediates phagocytosis of apoptotic cells, has been implicated in HBV infection and cancers. This study explored the polymorphisms of TIM3 gene in 535 patients with HBV‐related liver diseases including 213 chronic hepatitis, 178 cirrhosis and 144 HCC, 72 HBV infection resolvers and 182 healthy controls and analyzed the effects of these polymorphisms on the disease susceptibility and HCC traits. TIM3‐1541C/T, ‐1516G/T, ‐882C/T, ‐574G/T and +4259T/G polymorphisms were genotyped using polymerase chain reaction‐restriction fragment length polymorphism. Of the five polymorphisms genotyped, the allele T‐containing genotypes (GT + TT), allele T and allele T‐containing haplotype (CTCGT) of ‐1516G/T polymorphism were more frequent in HBV patients than in controls [P = 0.005, odds ratio (OR) = 2.300, 95% confidence interval (CI): 1.294‐4.088; P = 0.004, OR = 2.266, 95% CI: 1.297‐3.962; and P = 0.005, OR = 2.203, 95% CI: 1.260‐3.854, respectively]. The allele T‐containing genotypes and allele T of ‐1516G/T were associated with HCC tumor grade (P = 0.023 and P = 0.017, respectively) and lymph node metastasis (P = 0.024 and P = 0.017, respectively). These findings suggest that ‐1516G/T polymorphism in the promoter region of TIM3 gene may affect the disease susceptibility and HCC traits associated with HBV infection, potentially supporting the role of Tim‐3 in T‐cell dysfunction and exhaustion involved in persistent HBV infection and HCC development.Keywords
This publication has 26 references indexed in Scilit:
- Tim-3 expression on peripheral T cell subsets correlates with disease progression in hepatitis B infectionVirology Journal, 2011
- Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunityJournal of Experimental Medicine, 2010
- Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen–specific CD8+ T cell dysfunction in melanoma patientsJournal of Experimental Medicine, 2010
- Lymphoma endothelium preferentially expresses Tim-3 and facilitates the progression of lymphoma by mediating immune evasionJournal of Experimental Medicine, 2010
- T Cell/Transmembrane, Ig, and Mucin-3 Allelic Variants Differentially Recognize Phosphatidylserine and Mediate Phagocytosis of Apoptotic CellsThe Journal of Immunology, 2010
- Lack of association of TIM3polymorphisms and allergic phenotypesBMC Medical Genetics, 2009
- The costimulatory role of TIM moleculesImmunological Reviews, 2009
- Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infectionNature Immunology, 2008
- Characterization of Hepatitis B Virus (HBV)-Specific T-Cell Dysfunction in Chronic HBV InfectionJournal of Virology, 2007
- SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism lociCell Research, 2005